3631 results for «547»

Filter By

3631 results

Optimising bifurcation PCI: learning from randomised controlled trials

20 May 2026 – From EuroPCR 2026

This session delves into optimizing bifurcation PCI by examining contemporary European practices and outcomes from multiple randomized controlled trials. Key topics include multivessel TALENT trial results, 30-day outcomes of left main PCI with sirolimus-eluting stents from the NAGOMI COMPLEX study, comparative insights from the CROSS-LCX Registry...

Registries and trials in mitral TEER

20 May 2026 – From EuroPCR 2026

This comprehensive session reviews registries and clinical trials in mitral transcatheter edge-to-edge repair (TEER). It includes discussions on novel TEER systems, international consensus on PASCAL implants, anatomical predictors of procedural success, and long-term outcomes including ventricular and atrial remodeling after intervention, as well as emerging therapies...

Challenging TAVI access: exploring transfemoral boundaries and mastering alternative access

20 May 2026 – From EuroPCR 2026

This session investigates the boundaries of transfemoral access for TAVI and strategies to safely extend its use. It also provides a comprehensive review of facilitated transfemoral TAVI techniques and explores alternative access options, offering critical insights for managing challenging TAVI cases.

Challenging TAVI access: exploring transfemoral boundaries and mastering alternative access

Monotherapy vs. DAPT: striking the balance between ischemia and bleeding

20 May 2026 – From EuroPCR 2026

This session examines the balance between ischemic and bleeding risks by comparing monotherapy regimens and dual antiplatelet therapy (DAPT) following PCI. Key topics include clopidogrel versus aspirin monotherapy, aspirin discontinuation timing after ACS, and the impact of P2Y12 adherence on clinical outcomes in high-risk and oral...

Optimal timing of aspirin discontinuation: when early is too early?

20 May 2026 – From EuroPCR 2026

This session critically evaluates the optimal timing for aspirin discontinuation after PCI, discussing outcomes of aspirin-free strategies initiated within one month versus three months post-procedure. It considers differential effects of DAPT duration based on ACS presentation and bleeding risk, supported by meta-analyses and real-world data to...

Bifurcation PCI with complications - Part 1

20 May 2026 – From EuroPCR 2026

This session addresses complications encountered during bifurcation PCI through real-world cases involving stent dislodgement, entrapped guidewires, failed wiring techniques, and fractured devices. It highlights technical rescue maneuvers, the role of intravascular imaging, and long-term challenges encountered in managing complex bifurcation lesions to improve procedural success and...

Unusual complexities, uncommon complications and innovative solutions

20 May 2026 – From EuroPCR 2026

This session showcases innovative solutions to unusual complexities and rare complications in interventional cardiology. Through detailed case presentations, it examines ambiguous CTO management, giant coronary aneurysm complications post-PCI, and unforeseen issues arising from coronary atherectomy for calcified nodules.

Unusual complexities, uncommon complications and innovative solutions

Complex distal LM PCI challenges (trifurcations and more)

20 May 2026 – From EuroPCR 2026

Focusing on the intricacies of complex distal left main PCI, this session covers challenging trifurcation lesions and emergency interventions. It includes IVUS-guided approaches for trifurcation PCI, management of calcified left main trifurcations, and multidisciplinary team rescue strategies for unstable left main bifurcation disease.

Navigating the complexity of high bleeding risk

20 May 2026 – From EuroPCR 2026

Focusing on patients with high bleeding risk undergoing PCI, this session presents contemporary evidence on prevalence, procedural strategies with different stent types, antiplatelet therapy considerations including diabetic and sex-specific outcomes, and novel technologies such as sirolimus-coated balloons and machine learning models for restenosis prediction.

PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients With Acute Myocardial Infarction

03 Apr 2022

Nicola Ryan provides a PICOT analysis of PACMAN AMI: a double-blind, placebo-controlled, randomized trial presented at ACC 2022 and simultaneously published in JAMA.

Nicola Ryan

Author

Nicola Ryan
PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients With Acute Myocardial Infarction: A Double-blind, Placebo-controlled, Randomized Trial

RENOVATE-COMPLEX-PCI: Intravascular imaging-guided versus angiography-guided procedural optimization in complex percutaneous coronary intervention

06 Mar 2023

Daniele Giacoppo reports the main results of the RENOVATE-COMPLEX-PCI trial presented by Joo-Yong Hahn, from the Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, in a Late-Breaking Trial session at the American College of Cardiology (ACC) 2023 / World...

Daniele Giacoppo

Author

Daniele Giacoppo
RENOVATE-COMPLEX-PCI: Intravascular imaging-guided versus angiography-guided procedural optimization in complex percutaneous coronary intervention
Didn’t find what you were looking for?